Skip to main content

Find Clinical Trials

Home
Conditions
Advanced Renal Cell Carcinoma (aRCC)

Clinical trial condition

Advanced Renal Cell Carcinoma (aRCC)

Explore clinical trials studying Advanced Renal Cell Carcinoma (aRCC). Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Advanced Renal Cell Carcinoma (aRCC) trial results

Recruiting

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

NCT07188896

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma (aRCC), Carcinoma, +16 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

NCT07159191

Conditions: Advanced Renal Cell Carcinoma (aRCC)
Locations: Not specified

View Trial Details

Completed

Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients

NCT06345183

Conditions: Advanced Renal Cell Carcinoma (aRCC)
Locations: Cardinal Health Dublin, Ohio, United States

View Trial Details

Completed

Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

NCT04957160

Conditions: Advanced Renal Cell Carcinoma (aRCC)
Locations: Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

Royal Surrey County Hospital Guildford, United Kingdom

Barts Cancer Institute London, United Kingdom

Royal Marsden Hospital London, United Kingdom

View Trial Details